UCLA Hematology/Oncology - Westwood (Building 200 Suite 120) — Los Angeles, California

UCLA Hematology/Oncology - Westwood (Building 200 Suite 120) is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA Hematology/Oncology - Westwood (Building 200 Suite 120) has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Multiple Myeloma, Myelodysplastic Syndromes.

Sponsors: Pfizer, Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology/Oncology - Westwood (Building 200 Suite 120)?

UCLA Hematology/Oncology - Westwood (Building 200 Suite 120) has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology/Oncology - Westwood (Building 200 Suite 120) conducted?

UCLA Hematology/Oncology - Westwood (Building 200 Suite 120) has 2 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma, Myelodysplastic Syndromes.

Is UCLA Hematology/Oncology - Westwood (Building 200 Suite 120) accredited by Crixeo Health?

UCLA Hematology/Oncology - Westwood (Building 200 Suite 120) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematology/Oncology - Westwood (Building 200 Suite 120)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.